HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisabetta Corna Selected Research

BBR 3464 (BBR3464)

1/2006Molecular alterations of cells resistant to platinum drugs: role of PKCalpha.
7/2003Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elisabetta Corna Research Topics

Disease

16Carcinoma (Carcinomatosis)
01/2022 - 07/2003
13Neoplasms (Cancer)
01/2022 - 07/2003
2Melanoma (Melanoma, Malignant)
05/2021 - 06/2014
2Ovarian Neoplasms (Ovarian Cancer)
08/2012 - 03/2011
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Genomic Instability
08/2008
1Urinary Bladder Neoplasms (Bladder Cancer)
02/2005
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2004
1Osteosarcoma (Osteogenic Sarcoma)
07/2004
1Glioma (Gliomas)
03/2002
1Glioblastoma (Glioblastoma Multiforme)
03/2002

Drug/Important Bio-Agent (IBA)

7PlatinumIBA
01/2022 - 07/2003
7Cisplatin (Platino)FDA LinkGeneric
01/2022 - 07/2003
4Drug CombinationsIBA
05/2021 - 08/2012
3Histone Deacetylase InhibitorsIBA
01/2020 - 08/2012
3Platinum Compounds (Compounds, Platinum)IBA
11/2016 - 01/2006
3Pharmaceutical PreparationsIBA
11/2016 - 03/2006
2EnzymesIBA
05/2021 - 01/2012
2Histone Deacetylases (Histone Deacetylase)IBA
01/2020 - 06/2014
2Proteins (Proteins, Gene)FDA Link
03/2016 - 08/2008
2ErbB Receptors (EGF Receptor)IBA
03/2016 - 03/2008
2LigandsIBA
06/2014 - 03/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2014 - 03/2006
2Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2010 - 03/2008
2CamptothecinIBA
03/2010 - 02/2005
2ST 1481 (Gimatecan)IBA
03/2006 - 02/2005
2BBR 3464 (BBR3464)IBA
01/2006 - 07/2003
1caffeic acid phenethyl esterIBA
01/2022
1Ubiquitin-Specific ProteasesIBA
01/2022
1CurcuminIBA
01/2022
1Orlistat (Xenical)FDA Link
05/2021
1VemurafenibIBA
05/2021
1Mitogen-Activated Protein KinasesIBA
01/2020
1AZD 6244IBA
01/2020
1ricolinostatIBA
01/2020
1Histone Deacetylase 6IBA
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020
1SB 203580IBA
07/2019
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
07/2019
1statticIBA
07/2019
1MicroRNAs (MicroRNA)IBA
11/2016
1Small Interfering RNA (siRNA)IBA
03/2016
1Messenger RNA (mRNA)IBA
03/2016
1Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
03/2016
1Temozolomide (Temodar)FDA LinkGeneric
06/2014
1CC ChemokinesIBA
06/2014
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
06/2014
1ChemokinesIBA
06/2014
1CytokinesIBA
01/2014
1Caspase 3 (Caspase-3)IBA
01/2014
1Bortezomib (Velcade)FDA Link
08/2012
1Proteasome InhibitorsIBA
08/2012
1PoisonsIBA
01/2012
1Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2012
1tyrosyl-DNA phosphodiesteraseIBA
01/2012
1RetinoidsIBA
03/2011
13- (3'- adamantan- 1- yl- 4'- methoxybiphenyl- 4- yl)- 2- propenoic acidIBA
03/2011
13- (4'- hydroxy- 3'- adamantylbiphenyl- 4- yl)acrylic acidIBA
03/2011
1multidrug resistance-associated protein 1IBA
04/2010
1Adenosine Triphosphate (ATP)IBA
03/2010
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
03/2010
1DNA (Deoxyribonucleic Acid)IBA
02/2010
1Biological ProductsIBA
08/2008
1Glutathione Transferase (Glutathione S-Transferase)IBA
07/2008
1Proteasome Endopeptidase Complex (Proteasome)IBA
07/2008
1Gefitinib (Iressa)FDA Link
03/2008
1Topotecan (Hycamtin)FDA LinkGeneric
02/2005
1Topoisomerase I InhibitorsIBA
03/2002

Therapy/Procedure

3Therapeutics
07/2019 - 03/2002
1Castration
01/2020